亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Optimal medical treatment versus endovascular aortic repair in uncomplicated isolated abdominal aortic dissection

医学 四分位间距 外科 主动脉夹层 回顾性队列研究 单变量分析 解剖(医学) 主动脉修补术 病历 腹部外科 动脉瘤 内科学 主动脉 多元分析
作者
Sheng Su,Jitao Liu,Changjin Wang,Rui-Rong Chen,Yuanli Liu,Wenhui Huang,Songyuan Luo,Fan Yang,Jianfang Luo
出处
期刊:Journal of Vascular Surgery [Elsevier BV]
卷期号:77 (4): 1028-1036.e2
标识
DOI:10.1016/j.jvs.2022.10.036
摘要

To report the results of optimal medical treatment (OMT) and endovascular aortic repair (EVAR) in patients with uncomplicated isolated abdominal aortic dissection (IAAD).A retrospective review of 96 consecutive patients with uncomplicated IAAD (uIAAD) managed at a single tertiary vascular unit between January 2011 and July 2021 was conducted. Standard methods for univariate and survival analyses were used. The primary outcomes were all-cause mortality. Secondary end points included uIAAD progression, interventional complications, and follow-up aortic intervention.Initially, 53.1% of patients (51/96) were managed with OMT. No in-hospital deaths occurred. During follow-up, three patients died, and three and two patients who were initially managed with OMT subsequently required endovascular treatment and surgical management, respectively. Initially, 46.9% of patients (45/96) underwent EVAR. One patient died during hospital admission; nine patients had an endoleak after operation and one needed reintervention. Furthermore, during follow-up, five patients died; four patients needed reoperation, one surgery and three endovascular treatments. The overall long-term mortality was 8.4%, and follow-up aortic intervention rate was 9.5% (median follow-up, 54 months; interquartile range, 33-81 months) with no significant difference between groups. Of note, 12 patients (12.6%) suffered uIAAD progression, which was higher in the OMT group than EVAR group (10 [19.6%] vs 2 [4.5%]; P = .03).uIAAD may be managed safely by OMT with regular surveillance, despite the risk of disease progression. Compared with OMT, EVAR could significantly prevent uIAAD progression. For anatomically suitable patients with uIAAD progression and who are unresponsive to OMT, pre-emptive EVAR is a safe and feasible option.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Akim应助jin采纳,获得10
8秒前
神火完成签到,获得积分10
8秒前
英俊的铭应助无心采纳,获得10
9秒前
kento完成签到,获得积分0
13秒前
14秒前
李李完成签到,获得积分10
17秒前
hhhhhhh完成签到,获得积分10
17秒前
19秒前
19秒前
20秒前
李李发布了新的文献求助10
23秒前
fhg完成签到 ,获得积分10
24秒前
无心发布了新的文献求助10
25秒前
Jasper应助科研通管家采纳,获得10
35秒前
英姑应助科研通管家采纳,获得10
36秒前
36秒前
爆米花应助科研通管家采纳,获得10
36秒前
15198978346完成签到,获得积分20
39秒前
Crane完成签到,获得积分10
39秒前
50秒前
51秒前
52秒前
53秒前
染东发布了新的文献求助10
55秒前
科研通AI6.2应助huizi采纳,获得10
55秒前
快乐芷荷完成签到 ,获得积分10
58秒前
脑洞疼应助德文喵采纳,获得10
1分钟前
Prof.Z发布了新的文献求助10
1分钟前
1分钟前
weofihqerg完成签到,获得积分20
1分钟前
香蕉觅云应助张三采纳,获得10
1分钟前
体贴以筠发布了新的文献求助10
1分钟前
三三完成签到,获得积分10
1分钟前
NexusExplorer应助哭泣的擎汉采纳,获得30
1分钟前
1分钟前
1分钟前
白灼虾完成签到 ,获得积分10
1分钟前
流浪完成签到,获得积分10
1分钟前
1分钟前
1分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Modern Epidemiology, Fourth Edition 5000
Kinesiophobia : a new view of chronic pain behavior 5000
Molecular Biology of Cancer: Mechanisms, Targets, and Therapeutics 3000
Digital Twins of Advanced Materials Processing 2000
Propeller Design 2000
Weaponeering, Fourth Edition – Two Volume SET 2000
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 纳米技术 化学工程 生物化学 物理 计算机科学 内科学 复合材料 催化作用 物理化学 光电子学 电极 冶金 细胞生物学 基因
热门帖子
关注 科研通微信公众号,转发送积分 6012291
求助须知:如何正确求助?哪些是违规求助? 7567343
关于积分的说明 16138795
捐赠科研通 5159228
什么是DOI,文献DOI怎么找? 2763007
邀请新用户注册赠送积分活动 1742125
关于科研通互助平台的介绍 1633887